These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9125527)

  • 1. Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function.
    Ko YH; Delannoy M; Pedersen PL
    Biochemistry; 1997 Apr; 36(16):5053-64. PubMed ID: 9125527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein.
    Ko YH; Thomas PJ; Delannoy MR; Pedersen PL
    J Biol Chem; 1993 Nov; 268(32):24330-8. PubMed ID: 7693699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the C-terminal region.
    Lu NT; Pedersen PL
    Arch Biochem Biophys; 2000 Mar; 375(1):7-20. PubMed ID: 10683244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A domain mimic increases DeltaF508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia.
    Clarke LL; Gawenis LR; Hwang TC; Walker NM; Gruis DB; Price EM
    Am J Physiol Cell Physiol; 2004 Jul; 287(1):C192-9. PubMed ID: 15028554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into cystic fibrosis by structural modelling of CFTR first nucleotide binding fold (NBF1).
    Annereau JP; Stoven V; Bontems F; Barthe J; Lenoir G; Blanquet S; Lallemand JY
    C R Acad Sci III; 1997 Feb; 320(2):113-21. PubMed ID: 9181119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.
    Annereau JP; Wulbrand U; Vankeerberghen A; Cuppens H; Bontems F; Tümmler B; Cassiman JJ; Stoven V
    FEBS Lett; 1997 May; 407(3):303-8. PubMed ID: 9175873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.
    Annereau JP; Ko YH; Pedersen PL
    Biochem J; 2003 Apr; 371(Pt 2):451-62. PubMed ID: 12523935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator are extracellularly accessible.
    Gruis DB; Price EM
    Biochemistry; 1997 Jun; 36(25):7739-45. PubMed ID: 9201915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression, purification, and function of first nucleotide-binding fold of cystic fibrosis transmembrane conductance regulator.
    Ko YH; Pedersen PL
    Methods Enzymol; 1998; 292():675-86. PubMed ID: 9711591
    [No Abstract]   [Full Text] [Related]  

  • 10. The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase.
    Ko YH; Pedersen PL
    J Biol Chem; 1995 Sep; 270(38):22093-6. PubMed ID: 7545672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.
    Ko YH; Pedersen PL
    J Bioenerg Biomembr; 2001 Dec; 33(6):513-21. PubMed ID: 11804193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.
    Yike I; Ye J; Zhang Y; Manavalan P; Gerken TA; Dearborn DG
    Protein Sci; 1996 Jan; 5(1):89-97. PubMed ID: 8771200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies.
    Duffieux F; Annereau JP; Boucher J; Miclet E; Pamlard O; Schneider M; Stoven V; Lallemand JY
    Eur J Biochem; 2000 Sep; 267(17):5306-12. PubMed ID: 10951189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
    Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
    Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway.
    Qu BH; Thomas PJ
    J Biol Chem; 1996 Mar; 271(13):7261-4. PubMed ID: 8631737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR.
    Aleksandrov AA; Kota P; Aleksandrov LA; He L; Jensen T; Cui L; Gentzsch M; Dokholyan NV; Riordan JR
    J Mol Biol; 2010 Aug; 401(2):194-210. PubMed ID: 20561529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.
    Gentzsch M; Aleksandrov A; Aleksandrov L; Riordan JR
    Biochem J; 2002 Sep; 366(Pt 2):541-8. PubMed ID: 12020354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of the second nucleotide-binding fold in the CFTR chloride channel.
    Zerhusen B; Ma J
    FEBS Lett; 1999 Oct; 459(2):177-85. PubMed ID: 10518014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.